{"DataElement":{"publicId":"4101853","version":"1","preferredName":"Solid Neoplasm Confirmation Response Solid Neoplasm Response Type","preferredDefinition":"Information related to the verification of pathologic and/or clinical changes that result from treatment of cancer of body tissues other than blood, bone marrow, or the lymphatic system._The type of response related to a cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"Soli_Conf_Resp_Soli_Resp_Type","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"4101852","version":"1","preferredName":"Solid Neoplasm Confirmation Response","preferredDefinition":"Information related to the verification of pathologic and/or clinical changes that result from treatment of cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"Soli_Conf_Resp","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3838551","version":"1","preferredName":"Solid Neoplasm","preferredDefinition":"Cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"C9292","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E34BBF24-FC56-768F-E040-BB89AD4334A3","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-06","modifiedBy":"ONEDATA","dateModified":"2013-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4057013","version":"1","preferredName":"Confirmation Response","preferredDefinition":"Having been established or verified.:The pathologic and/or clinical changes that result from treatment. The changes may refer to eradication of detectable disease, stabilization of disease, or disease progression.","longName":"C25458:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF7A7F80-F27D-BDD3-E040-BB89AD4354F1","latestVersionIndicator":"Yes","beginDate":"2014-01-08","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-08","modifiedBy":"ONEDATA","dateModified":"2014-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F01E4F4A-6CBE-EC2F-E040-BB89AD4333F6","latestVersionIndicator":"Yes","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4101832","version":"1","preferredName":"Solid Neoplasm Response Type","preferredDefinition":"The type of response related to a cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"Soli_Resp_Type","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F01E4F4A-6C8E-EC2F-E040-BB89AD4333F6","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"ONEDATA","dateModified":"2014-01-16","deletedIndicator":"No"},{"value":"Non-target lesions","valueDescription":"Non-target lesions","ValueMeaning":{"publicId":"4118336","version":"1","preferredName":"Non-target lesions","longName":"4118336","preferredDefinition":"Non-target lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BEF55-0EC9-99E0-E040-BB89AD432543","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BEF55-0EE2-99E0-E040-BB89AD432543","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Target lesions","valueDescription":"Target lesions","ValueMeaning":{"publicId":"4118337","version":"1","preferredName":"Target lesions","longName":"4118337","preferredDefinition":"Target lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BEF55-0EEC-99E0-E040-BB89AD432543","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BEF55-0F05-99E0-E040-BB89AD432543","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Non-measurable disease","valueDescription":"Non-measurable disease","ValueMeaning":{"publicId":"2571805","version":"1","preferredName":"Non-measurable disease","longName":"2571805","preferredDefinition":"Non-measurable disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E58A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-08","modifiedBy":"SHIDED","dateModified":"2004-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BEF55-0F0F-99E0-E040-BB89AD432543","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Malignant lymph nodes","valueDescription":"Malignant lymph nodes","ValueMeaning":{"publicId":"4118338","version":"1","preferredName":"Malignant lymph nodes","longName":"4118338","preferredDefinition":"Malignant lymph nodes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BEF55-0F1A-99E0-E040-BB89AD432543","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BEF55-0F33-99E0-E040-BB89AD432543","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Measurable disease- RECIST criteria","valueDescription":"Measurable disease- RECIST criteria","ValueMeaning":{"publicId":"4118339","version":"1","preferredName":"Measurable disease- RECIST criteria","longName":"4118339","preferredDefinition":"Measurable disease- RECIST criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F10BEF55-0F3D-99E0-E040-BB89AD432543","latestVersionIndicator":"Yes","beginDate":"2014-01-28","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F10BEF55-0F56-99E0-E040-BB89AD432543","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-28","modifiedBy":"ONEDATA","dateModified":"2014-01-28","deletedIndicator":"No"},{"value":"Not a solid tumor","valueDescription":"Not a solid tumor","ValueMeaning":{"publicId":"4336882","version":"1","preferredName":"Not a solid tumor","longName":"4336882","preferredDefinition":"Not a solid tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA78D2E8-00D3-A49F-E040-BB89AD432947","latestVersionIndicator":"Yes","beginDate":"2014-05-28","endDate":null,"createdBy":"JONESN","dateCreated":"2014-05-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FA78D2E8-00EC-A49F-E040-BB89AD432947","beginDate":"2014-05-28","endDate":null,"createdBy":"JONESN","dateCreated":"2014-05-28","modifiedBy":"ONEDATA","dateModified":"2014-05-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4101831","version":"1","preferredName":"Solid Neoplasm Response Type","preferredDefinition":"Cancer of body tissues other than blood, bone marrow, or the lymphatic system.:Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.:Something distinguishable as an identifiable class based on common qualities.","longName":"C9292:C25755:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F01E4F4A-6C6B-EC2F-E040-BB89AD4333F6","latestVersionIndicator":"Yes","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"ONEDATA","dateModified":"2014-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F01E4F4A-6C7C-EC2F-E040-BB89AD4333F6","latestVersionIndicator":"Yes","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"CAMPBELB","dateModified":"2015-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4631580","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP","ClassificationSchemeItems":[{"publicId":"4631582","version":"1","longName":"Exceptional Responder CDEs","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"How was the response document","type":"Preferred Question Text","description":"How was the response documented for solid tumors?","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F01ED003-37AC-E216-E040-BB89AD4365D5","latestVersionIndicator":"Yes","beginDate":"2014-01-16","endDate":null,"createdBy":"ABRAHAML","dateCreated":"2014-01-16","modifiedBy":"CAMPBELB","dateModified":"2017-10-04","changeDescription":"Cleanup; Cleanup; 12/12/14 jc added Exceptional Responder CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}